25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cryosite Ltd
Buy, Hold or Sell?

Let's analyze Cryosite together

I guess you are interested in Cryosite Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cryosite Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cryosite Ltd

I send you an email if I find something interesting about Cryosite Ltd.

1. Quick Overview

1.1. Quick analysis of Cryosite (30 sec.)










1.2. What can you expect buying and holding a share of Cryosite? (30 sec.)

How much money do you get?

How much money do you get?
A$0.04
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
A$0.03
Expected worth in 1 year
A$-0.08
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$-0.05
Return On Investment
-6.2%

For what price can you sell your share?

Current Price per Share
A$0.80
Expected price per share
A$0.73 - A$0.9928
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cryosite (5 min.)




Live pricePrice per Share (EOD)
A$0.80
Intrinsic Value Per Share
A$0.20 - A$1.03
Total Value Per Share
A$0.23 - A$1.06

2.2. Growth of Cryosite (5 min.)




Is Cryosite growing?

Current yearPrevious yearGrowGrow %
How rich?$980.3k$1.8m-$901.9k-92.0%

How much money is Cryosite making?

Current yearPrevious yearGrowGrow %
Making money$1.2m$953.3k$291.6k23.4%
Net Profit Margin14.6%11.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Cryosite (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cryosite?

Welcome investor! Cryosite's management wants to use your money to grow the business. In return you get a share of Cryosite.

First you should know what it really means to hold a share of Cryosite. And how you can make/lose money.

Speculation

The Price per Share of Cryosite is A$0.8. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cryosite.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cryosite, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.03. Based on the TTM, the Book Value Change Per Share is A$-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cryosite.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.033.2%0.033.2%0.022.4%0.022.3%0.011.0%
Usd Book Value Change Per Share-0.02-2.3%-0.02-2.3%0.011.6%0.011.1%-0.01-0.8%
Usd Dividend Per Share0.011.3%0.011.3%0.010.8%0.010.9%0.010.7%
Usd Total Gains Per Share-0.01-1.0%-0.01-1.0%0.022.4%0.022.0%0.00-0.1%
Usd Price Per Share0.84-0.84-0.42-0.41-0.26-
Price to Earnings Ratio32.89-32.89-21.65-22.26-20.95-
Price-to-Total Gains Ratio-100.71--100.71-21.65--7.86-1.22-
Price to Book Ratio41.77-41.77-10.97-26.81-14.52-
Price-to-Total Gains Ratio-100.71--100.71-21.65--7.86-1.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.54128
Number of shares1847
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.020.01
Usd Total Gains Per Share-0.010.02
Gains per Quarter (1847 shares)-15.3929.95
Gains per Year (1847 shares)-61.55119.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
175-137-725565110
2150-273-134110130230
3225-410-196165194350
4300-546-258220259470
5375-683-320275324590
6450-819-382330389710
7525-956-444385454830
8600-1092-506440519950
9675-1229-5684955831070
10750-1365-6305506481190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%17.07.00.070.8%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%4.06.00.040.0%15.09.00.062.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.02.080.0%12.00.012.050.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%18.06.00.075.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cryosite Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.027-0.0270%0.019-245%0.013-311%-0.010-65%
Book Value Per Share--0.0300.0300%0.057-48%0.029+3%0.036-17%
Current Ratio--1.6571.6570%2.114-22%1.810-8%2.779-40%
Debt To Asset Ratio--0.9260.9260%0.877+6%0.935-1%0.844+10%
Debt To Equity Ratio--12.60512.6050%7.141+77%41.379-70%21.543-41%
Dividend Per Share--0.0150.0150%0.010+50%0.011+36%0.009+69%
Eps--0.0380.0380%0.029+31%0.028+36%0.012+211%
Free Cash Flow Per Share--0.0500.0500%0.023+121%0.023+116%0.015+241%
Free Cash Flow To Equity Per Share---0.021-0.0210%0.006-431%0.003-807%-0.004-83%
Gross Profit Margin--1.0001.0000%0.961+4%0.949+5%0.778+29%
Intrinsic Value_10Y_max--1.026--------
Intrinsic Value_10Y_min--0.204--------
Intrinsic Value_1Y_max--0.050--------
Intrinsic Value_1Y_min--0.016--------
Intrinsic Value_3Y_max--0.191--------
Intrinsic Value_3Y_min--0.053--------
Intrinsic Value_5Y_max--0.380--------
Intrinsic Value_5Y_min--0.094--------
Market Cap39047680.000-55%60523904.00060523904.0000%30506000.000+98%29529808.000+105%18962529.600+219%
Net Profit Margin--0.1460.1460%0.118+24%0.122+19%0.055+165%
Operating Margin--0.1630.1630%0.128+28%0.127+28%0.072+126%
Operating Ratio--0.8370.8370%0.872-4%0.873-4%0.935-10%
Pb Ratio26.948-55%41.76941.7690%10.965+281%26.812+56%14.523+188%
Pe Ratio21.222-55%32.89332.8930%21.651+52%22.259+48%20.955+57%
Price Per Share0.800-55%1.2401.2400%0.625+98%0.605+105%0.389+219%
Price To Free Cash Flow Ratio15.970-55%24.75424.7540%27.557-10%66.198-63%42.719-42%
Price To Total Gains Ratio-64.971+35%-100.705-100.7050%21.650-565%-7.864-92%1.217-8373%
Quick Ratio--1.5311.5310%2.239-32%1.724-11%2.556-40%
Return On Assets--0.0930.0930%0.062+50%0.062+50%0.032+190%
Return On Equity--1.2701.2700%0.506+151%2.573-51%1.291-2%
Total Gains Per Share---0.012-0.0120%0.029-143%0.024-151%-0.001-94%
Usd Book Value--980393.400980393.4000%1882301.200-48%956176.127+3%1174897.496-17%
Usd Book Value Change Per Share---0.018-0.0180%0.013-245%0.009-311%-0.006-65%
Usd Book Value Per Share--0.0200.0200%0.039-48%0.020+3%0.024-17%
Usd Dividend Per Share--0.0100.0100%0.007+50%0.007+36%0.006+69%
Usd Eps--0.0260.0260%0.020+31%0.019+36%0.008+211%
Usd Free Cash Flow--1654287.0001654287.0000%748996.200+121%765950.713+116%484661.029+241%
Usd Free Cash Flow Per Share--0.0340.0340%0.015+121%0.016+116%0.010+241%
Usd Free Cash Flow To Equity Per Share---0.014-0.0140%0.004-431%0.002-807%-0.002-83%
Usd Market Cap26419660.288-55%40950473.44640950473.4460%20640359.600+98%19979868.093+105%12830047.527+219%
Usd Price Per Share0.541-55%0.8390.8390%0.423+98%0.409+105%0.263+219%
Usd Profit--1244944.0001244944.0000%953329.400+31%912812.427+36%443258.116+181%
Usd Revenue--8533279.2008533279.2000%8075221.000+6%7476086.964+14%6392210.233+33%
Usd Total Gains Per Share---0.008-0.0080%0.020-143%0.016-151%-0.001-94%
 EOD+5 -3MRQTTM+0 -0YOY+19 -175Y+23 -1310Y+19 -17

3.3 Fundamental Score

Let's check the fundamental score of Cryosite Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1521.222
Price to Book Ratio (EOD)Between0-126.948
Net Profit Margin (MRQ)Greater than00.146
Operating Margin (MRQ)Greater than00.163
Quick Ratio (MRQ)Greater than11.531
Current Ratio (MRQ)Greater than11.657
Debt to Asset Ratio (MRQ)Less than10.926
Debt to Equity Ratio (MRQ)Less than112.605
Return on Equity (MRQ)Greater than0.151.270
Return on Assets (MRQ)Greater than0.050.093
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Cryosite Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.851
Ma 20Greater thanMa 500.761
Ma 50Greater thanMa 1000.822
Ma 100Greater thanMa 2000.915
OpenGreater thanClose0.800
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Cryosite Ltd

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through two segments: Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment offers specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological, and cell gene therapies depot services. The Cord Blood and Tissues Storage segment provides long term storage solutions for cord blood and tissue samples. The company serves research, medical, pharmaceutical, and biotechnology industries. Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.

Fundamental data was last updated by Penke on 2024-09-10 17:33:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cryosite earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 14.6% means that $0.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cryosite Ltd:

  • The MRQ is 14.6%. The company is making a huge profit. +2
  • The TTM is 14.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.6%TTM14.6%0.0%
TTM14.6%YOY11.8%+2.8%
TTM14.6%5Y12.2%+2.4%
5Y12.2%10Y5.5%+6.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ14.6%-2.7%+17.3%
TTM14.6%-9.4%+24.0%
YOY11.8%-5.1%+16.9%
5Y12.2%-3.2%+15.4%
10Y5.5%-0.3%+5.8%
4.3.1.2. Return on Assets

Shows how efficient Cryosite is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • 9.3% Return on Assets means that Cryosite generated $0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cryosite Ltd:

  • The MRQ is 9.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.3%TTM9.3%0.0%
TTM9.3%YOY6.2%+3.1%
TTM9.3%5Y6.2%+3.1%
5Y6.2%10Y3.2%+3.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3%-1.3%+10.6%
TTM9.3%-1.8%+11.1%
YOY6.2%-1.1%+7.3%
5Y6.2%-0.6%+6.8%
10Y3.2%-0.5%+3.7%
4.3.1.3. Return on Equity

Shows how efficient Cryosite is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • 127.0% Return on Equity means Cryosite generated $1.27 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cryosite Ltd:

  • The MRQ is 127.0%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 127.0%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ127.0%TTM127.0%0.0%
TTM127.0%YOY50.6%+76.3%
TTM127.0%5Y257.3%-130.3%
5Y257.3%10Y129.1%+128.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ127.0%-0.5%+127.5%
TTM127.0%-1.6%+128.6%
YOY50.6%-0.2%+50.8%
5Y257.3%-1.2%+258.5%
10Y129.1%-1.6%+130.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cryosite Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cryosite is operating .

  • Measures how much profit Cryosite makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • An Operating Margin of 16.3% means the company generated $0.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cryosite Ltd:

  • The MRQ is 16.3%. The company is operating efficient. +1
  • The TTM is 16.3%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ16.3%TTM16.3%0.0%
TTM16.3%YOY12.8%+3.5%
TTM16.3%5Y12.7%+3.5%
5Y12.7%10Y7.2%+5.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ16.3%-16.8%+33.1%
TTM16.3%-12.4%+28.7%
YOY12.8%1.1%+11.7%
5Y12.7%-0.4%+13.1%
10Y7.2%3.5%+3.7%
4.3.2.2. Operating Ratio

Measures how efficient Cryosite is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are $0.84 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cryosite Ltd:

  • The MRQ is 0.837. The company is less efficient in keeping operating costs low.
  • The TTM is 0.837. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.837TTM0.8370.000
TTM0.837YOY0.872-0.035
TTM0.8375Y0.873-0.035
5Y0.87310Y0.935-0.063
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8371.342-0.505
TTM0.8371.322-0.485
YOY0.8721.301-0.429
5Y0.8731.265-0.392
10Y0.9351.196-0.261
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cryosite Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cryosite is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.66 means the company has $1.66 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cryosite Ltd:

  • The MRQ is 1.657. The company is able to pay all its short-term debts. +1
  • The TTM is 1.657. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.657TTM1.6570.000
TTM1.657YOY2.114-0.457
TTM1.6575Y1.810-0.153
5Y1.81010Y2.779-0.969
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6572.012-0.355
TTM1.6572.112-0.455
YOY2.1142.492-0.378
5Y1.8102.718-0.908
10Y2.7793.246-0.467
4.4.3.2. Quick Ratio

Measures if Cryosite is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.53 means the company can pay off $1.53 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cryosite Ltd:

  • The MRQ is 1.531. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.531. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.531TTM1.5310.000
TTM1.531YOY2.239-0.708
TTM1.5315Y1.724-0.193
5Y1.72410Y2.556-0.832
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5311.141+0.390
TTM1.5311.238+0.293
YOY2.2391.674+0.565
5Y1.7242.025-0.301
10Y2.5562.360+0.196
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cryosite Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cryosite assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cryosite to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.93 means that Cryosite assets are financed with 92.6% credit (debt) and the remaining percentage (100% - 92.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cryosite Ltd:

  • The MRQ is 0.926. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.926. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.926TTM0.9260.000
TTM0.926YOY0.877+0.049
TTM0.9265Y0.935-0.008
5Y0.93510Y0.844+0.091
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9260.442+0.484
TTM0.9260.439+0.487
YOY0.8770.360+0.517
5Y0.9350.424+0.511
10Y0.8440.447+0.397
4.5.4.2. Debt to Equity Ratio

Measures if Cryosite is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 1,260.5% means that company has $12.60 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cryosite Ltd:

  • The MRQ is 12.605. The company is unable to pay all its debts with equity. -1
  • The TTM is 12.605. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ12.605TTM12.6050.000
TTM12.605YOY7.141+5.464
TTM12.6055Y41.379-28.774
5Y41.37910Y21.543+19.836
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ12.6050.640+11.965
TTM12.6050.669+11.936
YOY7.1410.487+6.654
5Y41.3790.666+40.713
10Y21.5430.721+20.822
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cryosite generates.

  • Above 15 is considered overpriced but always compare Cryosite to the Diagnostics & Research industry mean.
  • A PE ratio of 32.89 means the investor is paying $32.89 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cryosite Ltd:

  • The EOD is 21.222. Based on the earnings, the company is fair priced.
  • The MRQ is 32.893. Based on the earnings, the company is overpriced. -1
  • The TTM is 32.893. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD21.222MRQ32.893-11.672
MRQ32.893TTM32.8930.000
TTM32.893YOY21.651+11.243
TTM32.8935Y22.259+10.634
5Y22.25910Y20.955+1.304
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD21.222-0.502+21.724
MRQ32.893-0.898+33.791
TTM32.893-0.791+33.684
YOY21.651-0.088+21.739
5Y22.2591.074+21.185
10Y20.9552.553+18.402
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cryosite Ltd:

  • The EOD is 15.970. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 24.754. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 24.754. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD15.970MRQ24.754-8.784
MRQ24.754TTM24.7540.000
TTM24.754YOY27.557-2.803
TTM24.7545Y66.198-41.444
5Y66.19810Y42.719+23.479
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD15.970-0.762+16.732
MRQ24.754-1.088+25.842
TTM24.754-1.281+26.035
YOY27.557-3.128+30.685
5Y66.198-1.518+67.716
10Y42.719-2.464+45.183
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cryosite is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 41.77 means the investor is paying $41.77 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cryosite Ltd:

  • The EOD is 26.948. Based on the equity, the company is expensive. -2
  • The MRQ is 41.769. Based on the equity, the company is expensive. -2
  • The TTM is 41.769. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD26.948MRQ41.769-14.821
MRQ41.769TTM41.7690.000
TTM41.769YOY10.965+30.804
TTM41.7695Y26.812+14.957
5Y26.81210Y14.523+12.289
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD26.9481.908+25.040
MRQ41.7692.071+39.698
TTM41.7692.172+39.597
YOY10.9652.338+8.627
5Y26.8123.795+23.017
10Y14.5234.139+10.384
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cryosite Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets19,713
Total Liabilities18,264
Total Stockholder Equity1,449
 As reported
Total Liabilities 18,264
Total Stockholder Equity+ 1,449
Total Assets = 19,713

Assets

Total Assets19,713
Total Current Assets6,611
Long-term Assets13,102
Total Current Assets
Cash And Cash Equivalents 4,703
Net Receivables 1,406
Inventory 59
Other Current Assets 443
Total Current Assets  (as reported)6,611
Total Current Assets  (calculated)6,611
+/-0
Long-term Assets
Property Plant Equipment 3,710
Long-term Assets Other 8,362
Long-term Assets  (as reported)13,102
Long-term Assets  (calculated)12,072
+/- 1,030

Liabilities & Shareholders' Equity

Total Current Liabilities3,990
Long-term Liabilities14,274
Total Stockholder Equity1,449
Total Current Liabilities
Short-term Debt 179
Accounts payable 657
Other Current Liabilities 1,058
Total Current Liabilities  (as reported)3,990
Total Current Liabilities  (calculated)1,894
+/- 2,096
Long-term Liabilities
Long-term Liabilities  (as reported)14,274
Long-term Liabilities  (calculated)0
+/- 14,274
Total Stockholder Equity
Common Stock3,538
Retained Earnings -2,089
Total Stockholder Equity (as reported)1,449
Total Stockholder Equity (calculated)1,449
+/-0
Other
Cash and Short Term Investments 4,703
Common Stock Shares Outstanding 48,810
Current Deferred Revenue2,096
Liabilities and Stockholders Equity 19,713
Net Debt -2,258
Short Long Term Debt Total 2,445



5.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-30
> Total Assets 
4,048
4,359
3,525
4,403
4,661
5,114
6,398
7,249
7,355
7,682
8,625
9,770
11,362
11,192
9,123
9,657
9,827
7,744
23,172
23,502
21,993
21,503
22,647
19,713
19,71322,64721,50321,99323,50223,1727,7449,8279,6579,12311,19211,3629,7708,6257,6827,3557,2496,3985,1144,6614,4033,5254,3594,048
   > Total Current Assets 
2,848
3,232
2,264
2,811
2,282
2,540
3,132
3,830
3,030
3,306
4,348
5,993
7,860
8,290
6,266
6,938
7,613
6,382
6,947
5,594
5,997
7,051
7,986
6,611
6,6117,9867,0515,9975,5946,9476,3827,6136,9386,2668,2907,8605,9934,3483,3063,0303,8303,1322,5402,2822,8112,2643,2322,848
       Cash And Cash Equivalents 
2,754
2,898
1,635
2,076
1,348
1,302
1,582
1,975
1,327
2,045
2,911
4,525
5,777
6,252
4,167
3,652
5,089
4,536
3,920
4,062
3,881
5,341
4,731
4,703
4,7034,7315,3413,8814,0623,9204,5365,0893,6524,1676,2525,7774,5252,9112,0451,3271,9751,5821,3021,3482,0761,6352,8982,754
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
324
0
0
0
1,000
0
01,000000324000000000000000000
       Net Receivables 
70
281
513
567
774
1,073
1,335
1,678
1,403
1,171
1,246
1,157
1,451
1,700
1,627
2,668
2,180
1,274
579
963
1,670
1,213
1,727
1,406
1,4061,7271,2131,6709635791,2742,1802,6681,6271,7001,4511,1571,2461,1711,4031,6781,3351,07377456751328170
       Inventory 
2
7
20
17
24
27
28
49
53
46
28
53
66
62
90
120
82
24
23
48
53
47
60
59
59604753482324821209062665328465349282724172072
       Other Current Assets 
21
46
96
151
136
138
188
128
247
44
163
258
566
276
381
498
263
548
2,101
522
393
450
468
443
4434684503935222,10154826349838127656625816344247128188138136151964621
   > Long-term Assets 
1,200
1,127
1,260
1,592
2,379
2,574
3,265
3,419
4,324
4,377
4,277
3,777
1,793
1,878
1,847
1,770
1,478
679
394
17,908
15,996
14,452
14,661
13,102
13,10214,66114,45215,99617,9083946791,4781,7701,8471,8781,7933,7774,2774,3774,3243,4193,2652,5742,3791,5921,2601,1271,200
       Property Plant Equipment 
1,161
1,096
1,143
1,050
1,196
887
817
937
2,010
2,188
2,377
1,996
1,721
1,587
1,343
1,125
884
589
373
2,382
2,149
2,404
4,036
3,710
3,7104,0362,4042,1492,3823735898841,1251,3431,5871,7211,9962,3772,1882,0109378178871,1961,0501,1431,0961,161
       Intangible Assets 
9
410
0
0
0
50
348
279
0
0
142
124
72
291
504
645
595
91
21
20
16
12
8
0
0812162021915956455042917212414200279348500004109
       Long-term Assets Other 
31
31
118
541
1,183
1,637
1,552
1,474
1,551
1,435
1,117
998
-1,793
-1,878
-1,847
-986
-760
-401
-2,599
13,232
12,083
10,776
9,558
8,362
8,3629,55810,77612,08313,232-2,599-401-760-986-1,847-1,878-1,7939981,1171,4351,5511,4741,5521,6371,1835411183131
> Total Liabilities 
180
469
755
1,364
2,183
2,301
2,662
2,927
3,014
3,328
3,934
4,290
5,098
5,057
5,578
6,279
6,678
5,800
24,888
23,347
21,174
19,642
19,865
18,264
18,26419,86519,64221,17423,34724,8885,8006,6786,2795,5785,0575,0984,2903,9343,3283,0142,9272,6622,3012,1831,364755469180
   > Total Current Liabilities 
177
468
503
760
994
731
1,194
1,410
1,493
1,416
1,770
1,757
2,067
1,865
1,762
1,960
1,911
1,142
3,354
3,366
3,478
3,726
3,777
3,990
3,9903,7773,7263,4783,3663,3541,1421,9111,9601,7621,8652,0671,7571,7701,4161,4931,4101,194731994760503468177
       Short-term Debt 
4
4
1
301
486
172
0
0
0
0
694
612
-368
-393
-347
-370
-394
-425
-2,274
197
215
233
161
179
179161233215197-2,274-425-394-370-347-393-3686126940000172486301144
       Accounts payable 
152
346
448
308
264
393
440
476
459
328
434
437
722
482
298
450
387
163
240
389
627
460
632
657
657632460627389240163387450298482722437434328459476440393264308448346152
       Other Current Liabilities 
20
31
23
37
54
75
494
657
748
774
304
372
1,346
1,383
1,464
1,509
1,524
978
3,114
571
449
800
944
1,058
1,0589448004495713,1149781,5241,5091,4641,3831,346372304774748657494755437233120
   > Long-term Liabilities 
3
1
251
604
1,189
1,569
1,467
1,517
1,521
1,912
2,164
2,533
3,031
3,563
3,817
4,355
4,350
4,225
21,093
19,981
17,696
15,916
16,088
14,274
14,27416,08815,91617,69619,98121,0934,2254,3504,3553,8173,5633,0312,5332,1641,9121,5211,5171,4671,5691,18960425113
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,065
850
616
2,445
0
02,4456168501,0650000000000000000000
       Long term Debt 
5
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000015
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,262
1,065
850
2,606
0
02,6068501,0651,2620000000000000000000
       Other Liabilities 
0
0
251
604
1,189
1,570
1,467
1,517
1,520
1,912
2,164
2,533
3,030
3,563
3,817
4,319
4,767
4,659
21,534
19,358
17,288
15,299
13,643
0
013,64315,29917,28819,35821,5344,6594,7674,3193,8173,5633,0302,5332,1641,9121,5201,5171,4671,5701,18960425100
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
578
528
475
418
358
0
0358418475528578000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,232
11,900
10,604
9,351
8,156
0
08,1569,35110,60411,90013,232000000000000000000
> Total Stockholder Equity
3,868
3,890
2,770
3,039
2,478
2,813
3,736
4,321
4,340
4,355
4,691
5,481
6,264
6,135
3,544
3,378
3,149
1,943
-1,716
155
819
1,861
2,782
1,449
1,4492,7821,861819155-1,7161,9433,1493,3783,5446,1356,2645,4814,6914,3554,3404,3213,7362,8132,4783,0392,7703,8903,868
   Common Stock
5,875
6,631
6,681
7,816
7,816
8,036
8,036
8,139
8,139
8,139
8,139
8,139
8,139
8,205
5,862
5,862
5,862
5,862
5,862
5,862
5,862
5,979
5,979
3,538
3,5385,9795,9795,8625,8625,8625,8625,8625,8625,8628,2058,1398,1398,1398,1398,1398,1398,0368,0367,8167,8166,6816,6315,875
   Retained Earnings -2,089-3,197-4,118-5,515-6,167-7,647-3,959-2,718-2,483-2,556-2,309-2,114-2,897-3,687-4,021-4,025-4,033-4,480-5,402-5,481-4,861-3,911-2,741-2,006
   Accumulated Other Comprehensive Income 
-154
-277
-528
84
143
180
180
215
227
237
239
239
239
239
239
0
447
482
511
460
472
0
0
0
000472460511482447023923923923923923722721518018014384-528-277-154
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
154
277
528
0
0
0
0
0
0
0
0
0
0
0
239
0
-442
-442
-442
19
-347
0
-2,782
0
0-2,7820-34719-442-442-442023900000000000528277154



5.3. Balance Sheets

All numbers in thousands.




5.4. Cash Flows

All numbers in thousands.